Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.41 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.34 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | RAD52 | P43351 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5313840 | 0.93 | ALDH1A1 (0.47) | ALDH1A1HSD17B10HIF1ACYP1B1HPGD | |
| SCHEMBL23840 | 0.93 | ALDH1A1 (0.47) | ALDH1A1HSD17B10HIF1ACYP1B1HPGD | |
| Trolamine SCHEMBL11041061 | 0.91 | ALDH1A1 (0.36) | ALDH1A1HSD17B10HIF1ACYP1B1HPGD | |
| SCHEMBL9844906 | 0.86 | CYP1A2 (0.41) | ALDH1A1HSD17B10HIF1ACYP1B1HPGD | |
| SCHEMBL11515314 | 0.86 | ALDH1A1 (0.41) | ALDH1A1HSD17B10HIF1ACYP1B1HPGD | |
| SCHEMBL3176812 | 0.82 | ALDH1A1 (0.37) | ALDH1A1HSD17B10HIF1ACYP1B1HPGD | |
| SCHEMBL31656985 | 0.81 | ALDH1A1 (0.38) | ALDH1A1HSD17B10HIF1ACYP1B1HPGD | |
| SCHEMBL31657027 | 0.81 | ALDH1A1 (0.38) | ALDH1A1HSD17B10HIF1ACYP1B1HPGD | |
| SCHEMBL31657085 | 0.81 | ALDH1A1 (0.38) | ALDH1A1HSD17B10HIF1ACYP1B1HPGD | |
| SCHEMBL11145052 | 0.80 | TRPM4 (0.47) | ALDH1A1HSD17B10HIF1ACYP1B1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10073349-B2 | Chemically amplified resist material, pattern-forming method, compound, and production method of compound | OSAKA UNIVERSITY (JP) | 2018-09-11 | — | — | US | disclosed |
| US-20170052449-A1 | CHEMICALLY AMPLIFIED RESIST MATERIAL, PATTERN-FORMING METHOD, COMPOUND, AND PRODUCTION METHOD OF COMPOUND | OSAKA UNIVERSITY (JP) | 2017-02-23 | — | — | US | disclosed |
| EP-3133444-A1 | CHEMICALLY AMPLIFIED RESIST MATERIAL, PATTERN-FORMING METHOD, COMPOUND, AND PRODUCTION METHOD OF COMPOUND | OSAKA UNIVERSITY (JP) | 2017-02-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10073349-B2 | Chemically amplified resist material, pattern-forming method, compound, and production method of compound | RER1, POLR1A, FEM1B | ALDH1A1 1044/4885HSD17B10 4658/4885HIF1A 568/4885 |
| US-20170052449-A1 | CHEMICALLY AMPLIFIED RESIST MATERIAL, PATTERN-FORMING METHOD, COMPOUND, AND PRODUCTION METHOD OF COMPOUND | RER1, POLR1A, FEM1B | ALDH1A1 1044/4885HSD17B10 4658/4885HIF1A 568/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.